Opera Breast Cancer Trial

In the competitive field of oncology, Olema faced the challenge of meeting ambitious enrollment targets for their Phase III clinical trial, OPERA-01. To drive rapid enrollment, Olema needed to position themselves as a leader in the field, A patient recruitment tool infused with compelling messaging effectively engages potential participants, highlighting the benefits and importance of the OPERA-01 clinical trial. Both informative and persuasive, the tool leverages the brand’s established credibility to resonate with the target audience and encourage enrollment.